Companies › ORKA

ORUKA THERAPEUTICS INC (ORKA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000907654 · EDGAR filings · Updated 2026-07-15

ORUKA THERAPEUTICS INC (ORKA) has reported institutional ownership of 86.2%, with 184 institutional managers holding positions valued at $2.55B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-15 — Insider transaction reported (Form 4)
• 2026-07-15 — Notice of proposed sale filed (Form 144)
• 2026-07-13 — Insider transaction reported (Form 4)
• 2026-07-13 — Notice of proposed sale filed (Form 144)
• 2026-07-01 — Notice of proposed sale filed (Form 144)
• 2026-07-01 — SCHEDULE 13D/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ORUKA THERAPEUTICS INC has 184 institutional holders and institutional ownership of 86.2%.

Insider activity

Insiders reported 38 transactions (0 buys, 21 sells) across 7 reporting insiders, with a net reported value of −$1.66M.

Data flags from SEC filings

Related companies

CATALYST PHARMACEUTICALS INC (CPRX) · BEAM THERAPEUTICS INC (BEAM) · ARCUS BIOSCIENCES INC COM (RCUS) · IMMUNOME INC (IMNM) · TYRA BIOSCIENCES INC (TYRA) · PRIVIA HEALTH GROUP INC (PRVA)